ConductScience.org, home
TRAJ60: T cell receptor alpha joining 60 (pseudogene)
API referenceFor AI assistants

Gene · 28695

Papers3,708

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 3,708

Download this page as JSON
TitleJournalYearPMIDFound bySource
Systematic analysis of CDR contacts and pairing constraints between T cell receptor αβ chains.Bioinformatics202642485223PubTator, text miningPubMed
T-cell receptor alpha to beta chains binding prediction.Brief Bioinform202642418829PubTator, text miningPubMed
Human neonatal MR1T cells have more diverse TCR repertoires but reduced bacterial recognition than adult MR1T cells.Nat Commun202642373629PubTator, text miningPubMed
Preselection CD4+CD8+ thymocytes modulate TCR responsiveness following TCRβ selection.J Immunol202642285890PubTator, text miningPubMed
Clonal overlap and convergent clustering of T cell receptor signatures in Crohn's disease in monozygotic twins.Inflamm Bowel Dis202642243622PubTator, text miningPubMed
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.ACS Nano202641990155PubTator, text miningPubMed
Psoriasis in Difficult-to-Treat Areas: A Multicentre, Real-World Retrospective Study Analyzing the Impact of Non-Invasive Imaging Techniques (Dermoscopy, Reflectance Confocal Microscopy and Optical Coherence Tomography) to Monitor the Effectiveness of Risankizumab in the Treatment of Plaque Psoriasis of the Legs.
Clin Pract202641892490PubTator, text miningPubMed
γδ T cells at the interface of innate and adaptive immunity in cancer.J Immunother Cancer202641871873PubTator, text miningPubMed
Dengue infection elicits skin tissue-resident and circulating CD8+ T cells associated with protection from hospitalization.Sci Adv202641861003PubTator, text miningPubMed
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.Science202641855322PubTator, text miningPubMed
Human CD3 complex is required for the generation of T-cell receptor-like chimeric antigen receptor targeting WT1 in natural killer cells.Cancer Immunol Immunother202641843174PubTator, text miningPubMed
Beyond CAR-T and oncology: broadening chimeric antigen receptor technologies across cell types and diseases.Precis Clin Med202641836149PubTator, text miningPubMed
Differences in Shared T Cell receptor α Repertoire Associated with Recognition of Viral Antigens.Immunol Invest202641834523PubTator, text miningPubMed
Integrated reiterative pipeline for rapid epitope-based pan-alphavirus vaccines.Sci Adv202641811958PubTator, text miningPubMed
Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis.Signal Transduct Target Ther202641803093PubTator, text miningPubMed
Mechanistic Insights from Human Studies in Axial Spondyloarthritis: A T Cell Story.Curr Rheumatol Rep202641784664PubTator, text miningPubMed
TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how.J Immunother Cancer202641775434PubTator, text miningPubMed
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors.Res Sq202641756414PubTator, text miningPubMed
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.Cancer Immunol Immunother202641739190PubTator, text miningPubMed
RUMINA: high-throughput deduplication of unique molecular identifiers for amplicon and whole-genome sequencing with enhanced error correction.Bioinformatics202641734278PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/28695/papers

API referenceFor AI assistants